Vontobel Financial Products GmbH Share Price

Certificat

DE000VU8KDP2

Market Closed - Deutsche Boerse AG 18:52:34 26/06/2024 BST
93.62 USD -1.48% Intraday chart for Vontobel Financial Products GmbH
Current month-1.07%
1 month-2.24%
Date Price Change
26/06/24 93.62 -1.48%
25/06/24 95.03 -0.38%
24/06/24 95.39 +1.04%
21/06/24 94.41 -0.35%
20/06/24 94.74 +2.41%

Delayed Quote Deutsche Boerse AG

Last update June 26, 2024 at 06:52 pm

More quotes

Static data

Product typeAktienanleihen
Buy / SellCALL
Underlying PFIZER, INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VU8KDP
ISINDE000VU8KDP2
Date issued 15/06/2023
Strike 39 $
Maturity 20/12/2024 (177 Days)
Parity 0.04 : 1
Emission price 100 $
Emission volume N/A
Settlement Beides
Currency USD

Technical Indicators

Highest since issue 99.33 $
Lowest since issue 78.76 $

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
27.42 USD
Average target price
31.92 USD
Spread / Average Target
+16.39%
Consensus